Cyclo TherapeuticsCYTH

13F holders, Q2 2024 (June 30)
22holders
1new positions
1sold out
2famous investors
$1.27avg. 13F price*

At the end of Q2 2024, 22 institutions reported holding Cyclo Therapeutics Inc. (CYTH) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were EPIQ Capital Group, LLC ($1.0M), Founders Fund V Management, LLC ($610K) and Vanguard Group Inc. ($567K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Cyclo Therapeutics Inc.
CUSIP
23254X201
Latest filing quarter
Q4 2024

History

Number of 13F holders

0510152025 Q1 2024: 22Q1 2024Q2 2024: 22Q2 2024Q3 2024: 19Q3 2024Q4 2024: 22Q4 2024

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions1$31K
Exits1$93

All 13F filers, Q1 2024 → Q2 2024: 120,046 shares bought and 46,794 shares sold, net +73,252 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 22 holders

EPIQ Capital Group, LLC 0.37% Reduce -4.3% 817,270 $1.0M
Founders Fund V Management, LLC 72.16% No change 480,708 $610K
Vanguard Group Inc. 0.00% Add +12.6% 446,573 $567K
Geode Capital Management, LLC 0.00% Add +9.8% 175,418 $223K
Founders Fund VI Management, LLC 100.00% No change 110,023 $140K
BlackRock Inc. 0.00% Add +60.3% 59,510 $76K
State Street Corp. 0.00% No change 39,530 $50K
Citadel Advisors 0.00% New 24,670 $31K
Northern Trust Corp. 0.00% Reduce -0.1% 21,722 $28K
Wealth Enhancement Advisory Services, LLC 0.00% No change 20,400 $26K
Renaissance Technologies 0.00% Reduce -38.6% 13,356 $17K
UBS Group AG 0.00% Add +149.7% 12,053 $15K
Tower Research Capital LLC (TRC) 0.00% Reduce -24.1% 4,999 $6K
Wells Fargo & Company 0.00% Reduce -3.8% 4,391 $6K
Princeton Global Asset Management LLC 0.00% No change 3,766 $5K
Morgan Stanley 0.00% Reduce -0.6% 1,031 $1K
Royal Bank of Canada 0.00% No change 746 $1K
Bank of America Corp. 0.00% Add +677.8% 210 $266
JPMorgan Chase & Co. 0.00% No change 153 $194
Steward Partners Investment Advisory, LLC 0.00% No change 90 $114
Osaic Holdings, Inc. 0.00% No change 67 $85
Qube Research & Technologies Ltd 0.00% No change 21 $27

"% of holder's portfolio" is CYTH's weight in each manager's 13F, not the share of Cyclo Therapeutics Inc. the manager owns.